4:06 PM ET
8-K
Leadership Change
AbbVie Leadership Change
Jennifer L. Davis, a Class II director, notified AbbVie of her intent to resign from the Board of Directors effective November 2, 2026. Her departure follows her appointment as CEO of Align Technology, Inc. and is not due to any disagreement with the company.